ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0580

18F-FDG PET-MR Characterization of Aortitis in the IL1rn-/- Mouse Model of Giant-Cell Arteritis

Samuel Deshayes1, Caroline Baugé2, Pierre-Antoine Dupont2, Christophe Simard2, Hubert De Boysson1, Alain Manrique2 and Achille Aouba1, 1Department of Internal Medicine, UR4650 PSIR, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France, 2UR4650 PSIR, Normandie Univ, UNICAEN, Caen, France

Meeting: ACR Convergence 2022

Keywords: giant cell arteritis, Imaging, Interleukins, Mouse Models, Other, Nuclear Medicine

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Cytokines and Cell Trafficking Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Metabolic imaging is routinely used to demonstrate aortitis in patients with giant-cell arteritis. We aimed to investigate aortitis in BALB/c IL1rn-/- mice, a preclinical model of aortitis, using 18F-FDG Positron Emission Tomography–Magnetic Resonance (PET-MR).

Methods: Fifteen first-generation specific and opportunistic pathogen-free (SOPF) 9-week-old IL1rn-/- mice and 15 wild-type BALB/cAnN mice were investigated using 18F-FDG PET-MR imaging, gamma-counting and immunostainings (anti-CD4, -CD8, -CD11c, -CD20, -CD31, -CD63, -CD163, -interferon-γ, interleukin-1α, -1β, -6, -17A antibodies). In addition, 5 second-generation specific pathogen-free (SPF) 9-week-old IL1rn-/- mice also underwent 18F-FDG PET-MR. Aortic 18F-FDG uptake was assessed as the target-to-background ratio (TBR) using time-of-flight MR angiography as vascular landmarks.

Results: 18F-FDG uptake measured by PET or gamma-counting was similar in the first-generation SOPF IL1rn-/- mice and the wild-type group. However, the first-generation IL1rn-/- mice exhibited significantly more interleukin-1β (p=0.021) and interleukin-6 (p=0.019) positive cells within abdominal aorta compared to the wild-type group. In addition, the second-generation SPF group exhibited a significantly higher TBR (p=0.0068) than the wild-type mice on the descending thoracic aorta, unlike the first-generation SOPF IL1rn-/- mice.

Conclusion: Besides the involvement of IL-1 and IL-6 in the mouse model of IL1rn-/- aortitis, this study validates 18F-FDG PET-MR as a useful tool for noninvasive monitoring of aortitis in this preclinical model. By demonstrating an increased aortic glucose metabolism, specifically in second-generation SPF 9-week-old IL1rn-/- mice, but not in the first-generation SOPF IL1rn-/- mice, compared to the wild-type group, our data suggest a pathophysiological role of the microbiota in this aortitis model and open perspectives for further pathophysiological and therapeutic investigations in this preclinical model.

Supporting image 1

Results of histological stainings of mice aorta

Supporting image 2

Results of the PET quantification in first-generation specific and opportunistic pathogen-free 9-week-old BALB/c IL1rn-/- (n=15) or wild-type mice (n=13 or n=12 for the ascending thoracic aorta)

Supporting image 3

Results of the PET quantification in second-generation specific pathogen-free 9-week-old BALB/c IL1rn-/- (n=5) or wild-type mice (n=13 or n=12 for the ascending thoracic aorta)


Disclosures: S. Deshayes, None; C. Baugé, None; P. Dupont, None; C. Simard, None; H. De Boysson, None; A. Manrique, None; A. Aouba, Roche.

To cite this abstract in AMA style:

Deshayes S, Baugé C, Dupont P, Simard C, De Boysson H, Manrique A, Aouba A. 18F-FDG PET-MR Characterization of Aortitis in the IL1rn-/- Mouse Model of Giant-Cell Arteritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/18f-fdg-pet-mr-characterization-of-aortitis-in-the-il1rn-mouse-model-of-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/18f-fdg-pet-mr-characterization-of-aortitis-in-the-il1rn-mouse-model-of-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology